09.03.2015 12:47:43
|
POZEN Turns To Profit In Q4 - Quick Facts
(RTTNews) - POZEN Inc. (POZN), a pharmaceutical company committed to transforming medicine that transforms lives, posted fourth-quarter net income attributable to common stockholders of $7.0 million or $0.21 per share, compared to net loss of $2.2 million or $0.07 per share in the prior year period.
Operating expenses for the fourth quarter of 2014 totaled $3.1 million, as compared to $6.9 million for the comparable period in 2013. The decrease in operating expenses in the fourth quarter of 2014 was primarily a result of reduced staff, reduced non-cash compensation expense and lower YOSPRALA related costs.
Total revenue for the latest fourth-quarter rose to $9.89 million from $4.67 million in the comparable quarter last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu POZEN Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |